Journal of glaucoma
Journal of glaucoma
Audio Summaries
Every issue of Journal of glaucoma moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Journal of glaucoma.
Association Between Systemic Comorbidity Burden and Glaucoma Progression: A 5-Year Cohort Study
Jun 1, 2026
The authors aimed to determine whether a higher systemic comorbidity burden, as measured by the age-adjusted Charlson Comorbidity Index (age-CCI), is linked to increased odds of glaucoma progression over a five-year period. Their findings indicate that each one-point increase in age-CCI correlates with a significant rise in the likelihood of progressing from early to moderate and severe stages of glaucoma, suggesting that incorporating systemic health assessments could enhance glaucoma risk stratification and management.
Long-Term Patient Acceptability and Adherence to Suprachoroidal Telemetric Intraocular Pressure Monitoring in Glaucoma
Jun 1, 2026
The authors aimed to evaluate the long-term acceptability and adherence of glaucoma patients to the suprachoroidal telemetric intraocular pressure (IOP) sensor, EyeMate-SC, over a three-year period. Their findings indicate that patients demonstrated high acceptance and strong adherence to self-monitoring, with no significant decline in vision-related quality of life, suggesting that telemetric IOP monitoring can be effectively integrated into glaucoma management.
Outcomes of Ahmed Glaucoma Valve Implantation in the Ciliary Sulcus Versus the Anterior Chamber
May 19, 2026
The authors aimed to compare the surgical outcomes of Ahmed glaucoma valve (AGV) implantation through the ciliary sulcus (CS) versus the anterior chamber (AC) in terms of intraocular pressure (IOP) control and corneal endothelial cell loss. Their findings indicate that while AGV-CS implantation has similar success rates for IOP control as AGV-AC, it is associated with more intraoperative challenges and postoperative hyphema, yet results in significantly less corneal endothelial cell loss. Thus, with proper technique, CS can be a viable option for refractory glaucoma treatment.